1. Blaunstein, Ancel: Pathology of the female, Genital
Tract. 2.ª ed. 1982.
2. Candy J., and M.R. Abell: Progestogen induced
adenomatous hiperplasia of the uterine cervix. lama 203: 323, 1968.
3. Govan A.D.T., Black W.P., and Sharp I.L. Aberrant
glandular polypi of the uterine cervix associated with contraceptive pills: pathology and
pathogenesis. J. Clin. Pathology 22: 84, 1969.
4. Kyriakos M., Kempson R.L., and Koniker N.E. A Clinical
and pathologic study of endocervical lesions associated with oral contraceptives. Cancer
22: 99, 1968.
5. Kyriakos M., Kempson R.L., and Konikov. A Clinical and
pathology study of endocervical lesions associated with oral contraceptivos. Cancer 22:
99-110, 1968.
6. Kyriakos M., Kempson R.L., and Konikov. A lipical
endocervical hiperplasia in women taking oral contraceptivos.
7. Laines, and Taylor's.: Gynecological Pathology. Boston
1962.
8. Maqueo M., Azuela J.C., Calderson J.L., and Goldzicher
J.W. Morphology of the cervix in women treated with synthetic progestins Am. J. Obstet.
Gynecol. 96: 994, 1966.
9. Nichols T.M., and Fidler H.K. Microglandular
hyperplasia in cervical cone biopsies taken for suspicious and positive cytology. Am. J.
Clin. Pathol. 56: 424, 1971.
10. Novak E., Woodruff D. Ginecología y Obstetricia
1972.
11. Marcuse M., Peter. Diagnostic pathology in gynecology
and obstetrics 1966.
12. Taylor H.B., Irey N.S. and Norris H.L. Atipical
endocervical hyperplasia in women taking oral contraceptives. Jama 202: 637, 1967.